Skip to main content

Table 1 The inclusion and exclusion criteria for this study

From: Patient-reported outcome (PRO)-based symptom assessment in patients with advanced lung cancer receiving first-line combination immunotherapy: a protocol for a multicenter, prospective, observational study

Inclusion criteria

Exclusion criteria

✓ Pathologically confirmed advanced or stage IV primary lung cancer who had no surgical indicators.

× Age < 18 years old at the time of informed consent.

✓ Scheduled to receive combination immunotherapy as the first-line treatment.

× Cognitive impairment or inability to understand the research content.